German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in Britain using the same mRNA technology, the company said on Friday.
Jan 6, 2023
0
40
Messenger RNA vaccine technology, once an arcane area of research, became household terminology because of the COVID-19 pandemic, and now scientists are working on an mRNA flu vaccine strategy that, at least in this study, ...
Nearly three years after it was first identified in China, the coronavirus is now spreading through the vast country. Experts predict difficult months ahead for its 1.4 billion people.
Dec 23, 2022
0
5
Within a study by investigators at Weill Cornell Medicine and NewYork-Presbyterian, the long-term immune response to SARS-CoV-2 mRNA vaccination was similar in pregnant individuals and non-pregnant individuals of reproductive ...
Dec 13, 2022
0
18
People infected with HIV who receive antiretroviral therapy form antibodies against SARS-CoV-2 after being vaccinated against COVID with mRNA vaccines. Their immune response to the vaccination is, however, less strong than ...
Dec 9, 2022
0
4
China is the only major country which, until now, has continued to enforce a zero-COVID strategy. Other countries, including Australia, New Zealand and Singapore, also sought to eliminate COVID entirely earlier in the pandemic. ...
Dec 8, 2022
0
10
mRNA COVID-19 vaccines are less effective against omicron infections than other variants. A study published December 1 in the open access journal PLOS Medicine by Margaret L. Lind at the Yale School of Public Health and colleagues ...
Dec 1, 2022
0
43
Malaria is found in more than 90 countries around the world, causing 241 million cases and an estimated 627,000 deaths every year. Vaccines are one intervention that could help eliminate this deadly disease, yet a highly ...
Dec 1, 2022
0
103
The effectiveness of COVID-19 vaccines in preventing death remains high in children and adolescents regardless of the predominant circulating variant, suggests a large study from Argentina published by The BMJ today.
Nov 30, 2022
2
25
Pfizer-BioNTech and Moderna are currently developing and testing various "combined" vaccines to guard against diseases such as COVID-19, influenza and RSV (respiratory syncytial virus) in one single injection.
Nov 30, 2022
0
13
